People with IBS should still get regular screenings for colon cancer. Dispelling these misconceptions doesn’t mean that you shouldn’t seek treatment for IBS. The knowledge may help you feel ...
About Immuron Immuron Limited (ASX: IMC, NASDAQ: IMRN), is an Australian biopharmaceutical company focused on developing and ...
Sometimes there are clear triggers, but often no clear cause can be found.” Irritable bowel syndrome is a disorder of the ...
The global irritable bowel syndrome treatment market size was valued at USD 3.48 billion in 2024 and is projected to reach ...
IBS-D is a subtype of IBS characterized by diarrhea. The triggers can vary among different people, but knowing finding out your potential triggers can help improve your daily life. Lifestyle ...
Probiotics, which refer to living microorganisms, are another possible treatment for IBS. They are similar to the microorganisms typically present in the digestive tract and may help treat IBS ...
Patients with irritable bowel syndrome are more likely to benefit from a diet that eliminates any food triggering an IgG ...
Robert, who was diagnosed with IBS at 20, remembers being told to "eat ... For example, following a gluten-free diet to treat celiac disease can make stools firmer by reducing inflammation in ...
Immuron will launch ProIBS® for the treatment of symptoms related to IBS in the retail pharmacy sales channel. Immuron has been a leader in digestive health in Australia for many years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback